NICOLE FLANAGAN: Open Payments
NPI 1093757916 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 10 payments from 6 companies in 2025. Trend: 2023 $1,047 · 2024 $890 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $236 |
| Janssen Pharmaceuticals, Inc | 1 | $146 |
| Neurocrine BioSciences, Inc. | 2 | $143 |
| Alkermes, Inc. | 1 | $104 |
| E.R. Squibb & Sons, L.L.C. | 1 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
Products named: REXULTI, SPRAVATO, LYBALVI, COBENFY, INGREZZA, TRINTELLIX.
Industry payments across RI — which companies pay providers there.
